1. Impact of Technology on Quality & Safety Initiatives

2. Dual Sign Levels of Dual Sign at MetroHealth Why Dual Sign?
Joint Commission and Institute for Safe Medication Practices require dual signoff for high-alert medications
Patient Safety with High Risk Drugs
Nationwide Approaches to improve safety
Medication Level (ERX)
Medication in all locations
Heparin
Profile Level
Nursing Students
Department Level – Global
Medications given at a certain area - NICU
Department – Drug Specific
Certain medications
Certain departments
MAR Action – Exclusions
Specific Mar actions can be excluded from requirement

3. !! Symbol = Dual Signoff Required

4. Outcomes: Significant Heparin Errors

5. Barcode Medication Administration: BCMA
Why BCMA?
Patient Safety Initiative
U.S Department of Health & Human Services
“Errors associated with medications are the most frequent cause of adverse medical events”
Meaningful Use: Stage 2 Requirement
HIMSS Stage 6
Closed loop mediation
administration
HIMSS Stage 7:
Expressed Breast Milk
Blood Products

6. Patient & Medication Scanning Compliance

7. Best Practice Alerts: BPA
What are BPAs?
MetroHealth Examples
Provide targeted, patient-specific clinical guidance to end-users
Versatile decision support tool
Scan patient’s entire record
Display notifications based on key pieces of clinical data
Lab results
Assessment data
Medications
Diagnoses
Histories
Include links to actions
Order placement
Care plans
Ebola Screening
Identifying patient’s at risk
Alerting clinical team members
Immunizations
Screening reminders
Order placement
Administration reminders
Heart Failure Discharge Instructions
Reminder based on Problem List
VTE Risk Assessment
Assessment reminder
Contraindication documentation
Restraints
Incorporate Care Plan